Scott Gottlieb to Leave FDA
Scott Gottlieb, MD, deputy commissioner for medical and scientific affairs at the US Food and Drug Administration (Rockville, MD, www.fda.org), will leave the agency effective January 16, 2007.
Scott Gottlieb, MD, deputy commissioner for medical and scientific affairs at the US Food and Drug Administration (Rockville, MD, www.fda.org), will leave the agency effective January 16, 2007. He will return to the American Enterprise Institute, a Washington-based think tank, where he as previously fellow prior to joining FDA. Gottlieb joined FDA as deputy commissioner in July 2005. Since then he has worked on a number of significant policy initiatives including efforts to improve the advisory committee process and to make the agency’s approaches regarding communication of risk information to the pubic more effective.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
